TEL AVIV, ISRAEL–(Marketwired – June 05, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Arteriae Sp. z o.o. sp.k, a leading medical […]
Neuro
InspireMD Announces Appointment Of Paul Stuka As Chairman Of The Board
TEL AVIV, ISRAEL–(Marketwired – June 02, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that Paul Stuka, who has served on the Company’s Board of Directors since 2011, […]
InspireMD Announces Publication of the IRON-GUARD Registry in EuroIntervention
Press Release – InSpireMD BOSTON, MA—May 17, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced the publication of the Investigator Initiated IRON-GUARD Italian clinical registry in the peer reviewed journal EuroIntervention, which […]
W. L. Gore & Associates Announces Positive Results From REDUCE Clinical Study For PFO Closure
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech […]
Healthcare Veteran John Fletcher Joins MRI Interventions (MRIC)’ Board of Directors
IRVINE, Calif., May 11, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) is pleased to announce that John Fletcher has been appointed to MRI Interventions’ Board of Directors. Mr. Fletcher, founder and managing partner of Fletcher Spaght, Inc., brings more than 30 years of experience in healthcare with an emphasis […]
Comprehensive Stroke Centers are Key to Positive Outcome
By Ken Dropiewski In the field of stroke treatment, there is a saying “time is brain.” This is because every minute with a clot a patient loses millions of brain cells. Stroke patients living near one to the nation’s Comprehensive Stroke Centers (CSC) are luckier than most. In 2015, 81 […]
MRI Interventions (MRIC) Release: Publication Provides Guidelines To Reduce Transportation Risks Associated With Neurosurgical Laser Ablation Multi-Site Workflows
IRVINE, Calif., April 24, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced that the reduced patient risk associated with a One-Room, One-Procedure workflow for laser ablation has been reviewed in the journal of the American Society for Healthcare Risk Management (AHRM) April issue. The findings indicate a one […]
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
NEWS PROVIDED BY Codman Neuro | 10 Apr, 2017, 07:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Codman Neuro today announced the acquisition of Neuravi Limited, a privately held Irish company dedicated to advancing neurovascular therapies and improving clinical outcomes for acute ischemic stroke patients. This acquisition, and the recent […]
Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation
NEWS PROVIDED BY Janssen Pharmaceuticals, Inc. | 03 Apr, 2017, 08:00 ET TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation […]
Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices
OLATHE, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US Patents 9,572,697 and 9,572,698 covering its Ballstent Microcatheter™ for embolization of cerebral aneurysms, and its Blockstent Microcatheter™ for embolization of peripheral […]